Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines
The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows
About 250+ women riders participate in the awareness ride where free breast screening camp were conducted
Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Social media emerges as the primary channel for health-related scams, while influencer endorsements and AI-generated content amplify risks for consumers
The company said the safety profile remained consistent with earlier studies and was considered manageable
The FDA has granted Priority Review, setting a target decision date of 9 October 2026, potentially accelerating access to a new treatment option for a subset of patients with high-risk colon cancer characterized
Researchers emphasized that the benefit persisted well beyond the treatment period, reinforcing the clinical rationale for time-limited therapy in selected patients
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Subscribe To Our Newsletter & Stay Updated